Dinesh V. Ph D. Patel serves as Executive at Protagonist Therapeutics, Inc, where they oversee executive responsibilities. Since joining the company, Dinesh V. Ph D. Patel has executed 60 insider transactions totaling $9.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 2, 2018 involved exercising options for 20,000 shares valued at $23.2K.
Dinesh V. Ph D. Patel currently holds 120,200 shares of Protagonist Therapeutics, Inc (PTGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dinesh V. Ph D. Patel has been a net seller of PTGX stock. They have purchased $168.5K and sold $9.3M worth of shares.
Dinesh V. Ph D. Patel's most recent insider trade was on Apr 2, 2018, when they sold 20,000 shares at $1.16 per share.
Get notified when new Form 4 filings are submitted
| 11,298 |
| $0.87 |
| Discretionary |
| Feb 28, 2018 | PTGX | $0 | Award | 25,000 | $N/A | Discretionary |
| Dec 21, 2017 | PTGX | $160.6K | Sale | 8,210 | $19.56 | Discretionary |
| Dec 21, 2017 | PTGX | $15.5K | Option Exercise | 8,210 | $1.89 | Discretionary |
| Dec 20, 2017 | PTGX | $3.4K | Option Exercise | 1,790 | $1.89 | Discretionary |
| Dec 20, 2017 | PTGX | $35.0K | Sale | 1,790 | $19.55 | Discretionary |
| May 9, 2017 | PTGX | $22.2K | Option Exercise | 19,099 | $1.16 | Discretionary |
| Apr 6, 2017 | PTGX | $23.2K | Option Exercise | 20,000 | $1.16 | Discretionary |
| Mar 10, 2017 | PTGX | $14.2K | Option Exercise | 16,362 | $0.87 | Discretionary |